Biotage logo

Biotage

Stock
Stock
ISIN: SE0000454746
Ticker: BIOT
SE0000454746
BIOT

Price

Precio

GRÁFICO POR

Dividendos históricos y previsiones

 


0,114

GRÁFICO POR

Preguntas más frecuentes

Biotage's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0,323. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Biotage's stock, with a consensus target price of 14,63 US$. Analyst ratings provide insights into the stock's expected performance.
En los últimos doce meses, Biotage registró unos ingresos de 197,91 MUS$.
El beneficio antes de intereses, impuestos, depreciaciones y amortizaciones (EBITDA) de Biotage en los últimos doce meses es de 47,13 MUS$. El EBITDA mide los resultados financieros globales de la empresa.
Biotage tiene un flujo de caja libre de 26,64 MUS$. El flujo de caja libre indica el efectivo generado después de contabilizar las salidas de efectivo para apoyar las operaciones y los activos de capital.
Biotage emplea aproximadamente a 673 personas. Opera en el sector Sanidad, concretamente dentro de la industria Especialidades médicas.

Finanzas

GPA (TTM) 
0,323
Ingresos últimos 12 meses (TTM) 
197,91 MUS$
EBITDA (TTM) 
47,13 MUS$
Flujo de caja libre (TTM) 
26,64 MUS$

Calificación de los analistas

El precio objetivo es 14,63 US$ y la acción ha sido analizada por 1 analistas.

Comprar

0

Mantenga

1

Vender

0

Información

Biotage AB is a Swedish life science company specializing in advanced laboratory technologies and workflow solutions that support drug discovery, development, and analytical testing to improve human health. The company is based in Uppsala, Sweden. The company offers a comprehensive portfolio of systems, consumables, reagents, and accessories focused on chemical synthesis, purification, evaporation, and sample extraction and clean-up. Product categories include organic and peptide synthesis, biomolecule purification, flash chromatography, solid-phase and supported liquid extraction, filtration, and evaporation technologies. Biotage provides automated sample preparation workstations, advanced peptide synthesizers, specialized solid-supported reagents, chromatography resins, prepacked columns, cartridges, and plates for various purification needs. The company's solutions are used in bioanalysis, forensic toxicology, environmental testing, food safety, doping control, and biomolecule purification, and are supported by knowledge resources, customer service, application support, and software tools. The company serves customers in pharmaceutical, biotech, contract research and manufacturing, clinical, forensic, academic laboratories, and organizations focused on food safety, clean water, and environmental sustainability. and has a global presence of subsidiaries in several regions. The company was founded in 1969 by Bengt Falk, Bertil Pettersson, Björn Lennart Ekström, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Neil Goldsmith, Pal Nyrén, Sheridan G. Snyder. Frederic Vanderhaegen has been the CEO of the company since 2024.

Empleados
673
Industrias
Especialidades médicas
Sector
Sanidad

Identificador

Número de Identificación Internacional de Valores (ISIN)
SE0000454746
Teletipo de bolsa (ticker) principal
BIOT

Knockouts

Datos LSX · Datos financieros de FactSet
Únase a la conversación